MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-06-0030455
Sirrus Pharmaceuticals Private Limited
Sirrus Pharmaceuticals Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹61.17 Lakh
▲ 153% YoY
Net profit · FY 2025
₹95,425
Net margin 1.6%
EBITDA · FY 2025
₹10.59 Lakh
EBITDA margin 17.3%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
18 yrs
Est. 2008
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Sirrus Pharmaceuticals Private Limited
Data last updated:
Sirrus Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 07 November 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2008PTC184762. Its GSTIN is 07AAMCS6398G1ZP (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Chandra Kanta Midha (Whole-Time Director) and Hemant Kumar (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 153 Venus Appartment Sector – 9 Rohini, New Delhi, Delhi, India – 110085.
As per the financials filed for FY 2025, the company reported a revenue of ₹61.17 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹95,425 (net margin 1.6%) and EBITDA of ₹10.59 Lakh (EBITDA margin 17.3%). Revenue has declined at a compounded annual rate (CAGR) of 12% over three years and 18% over five years.
Sirrus Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-06-0030455). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24232DL2008PTC184762
Registration Number 184762
Incorporation Date 07 November 2008
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-06-0030455
Key People
Chandra Kanta Midha Whole-Time Director Hemant Kumar Whole-Time Director Vandana Midha Whole-Time Director Recognitions & Rankings of Sirrus Pharmaceuticals
Contact details
Sirrus Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address153 Venus Appartment Sector – 9 Rohini, New Delhi, Delhi, India – 110085
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Sirrus Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Sirrus Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Sirrus Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Sirrus Pharmaceuticals Private Limited, buy the company report.
Financials of Sirrus Pharmaceuticals Private Limited
FY 2025 filings availableSirrus Pharmaceuticals Private Limited reported revenue of ₹61.17 Lakh (up 153% YoY) for FY 2025.
Revenue · FY 2025
₹61.17 Lakh ▲ 153%
Net profit · FY 2025
₹95,425 margin 1.6%
EBITDA · FY 2025
₹10.59 Lakh margin 17.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 153%
3 years · compounded
▼ 12%
5 years · compounded
▼ 18%
EBITDA CAGR growth
1 year
▲ 250%
3 years · compounded
▼ 11%
5 years · compounded
▼ 8%
Revenue rose 153% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 18%. EBITDA rose 250% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.59 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹95,425 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.3% | ||||
| Net Profit Margin | 1.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sirrus Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sirrus Pharmaceuticals Private Limited
Sirrus Pharmaceuticals has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandra Kanta Midha | Whole-Time Director | 12 Aug 2013 | 13 Years 2 Months | Current |
| Hemant Kumar | Whole-Time Director | 25 May 2015 | 11 Years 5 Months | Current |
| Vandana Midha | Whole-Time Director | 07 Nov 2008 | 18 Years 0 Months | Current |
Peer comparison
Sirrus Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Harcare Life Sciences Private Limited | ₹61.36 Lakh (FY 2024) | 102.0% | Ahmedabad, Gujarat, India | |||
| Inhale Pharmaceuticals Private Limited | ₹61.33 Lakh (FY 2024) | 8.0% | Lucknow, Uttar Pradesh, India | |||
| Khusboo Distributors Private Limited | ₹61.32 Lakh (FY 2025) | -57.0% | Noida, Uttar Pradesh, India | |||
| Leron Chem Private Limited | ₹61.18 Lakh (FY 2025) | -37.0% | Delhi, India | |||
| Sirrus Pharmaceuticals Private Limitedthis company | ₹61.17 Lakh (FY 2025) | ₹95,425 | 1.6% | 153.0% | New Delhi, Delhi, India |
To see the full peer comparison of Sirrus Pharmaceuticals Private Limited, buy the company report.
Auditor
Sirrus Pharmaceuticals Private Limited is audited by U K J & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| U K J & ASSOCIATES | FY 2021 | 024608N |
Shareholding
The shareholding of Sirrus Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sirrus Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sirrus Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sirrus Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sirrus Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAMCS6398G1ZP | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sirrus Pharmaceuticals Private Limited, buy the company report.
Recent activity
Sirrus Pharmaceuticals Private Limited has 8 board changes on record since 2008: 3 appointments and 5 cessations. The latest: Chandra Kanta Midha ceased to be Director on 20 Nov 2017.
AGM
Sirrus Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Sirrus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Chandra Kanta Midha ceased to be Director.
Ceased
Hemant Kumar ceased to be Director.
Ceased
Vandana Midha ceased to be Director.
Appointed
Hemant Kumar was appointed as Whole-Time Director.
Appointed
Chandra Kanta Midha was appointed as Whole-Time Director.
Ceased
Pawan Dawar ceased to be Director.
Ceased
Shyam Sunder Dua ceased to be Director.
Appointed
Vandana Midha was appointed as Whole-Time Director.
Incorporation
07 Nov 2008
Sirrus Pharmaceuticals Private Limited was registered on 07 Nov 2008 with Roc Delhi & aged 18 years 4 days as per MCA records.
Frequently asked questions
Sirrus Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 07 November 2008 (18+ years old) and is registered under CIN U24232DL2008PTC184762.
Sirrus Pharmaceuticals has 3 current directors:
- Chandra Kanta Midha - Whole-Time Director
- Hemant Kumar - Whole-Time Director
- Vandana Midha - Whole-Time Director
The latest financial statements of Sirrus Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sirrus Pharmaceuticals is 07AAMCS6398G1ZP, registered in Delhi.
The CIN (Corporate Identification Number) of Sirrus Pharmaceuticals is U24232DL2008PTC184762. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sirrus Pharmaceuticals was incorporated on 07 November 2008, making it 18+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Sirrus Pharmaceuticals by revenue are Harcare Life Sciences Private Limited, Inhale Pharmaceuticals Private Limited, Khusboo Distributors Private Limited, Leron Chem Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Chandra Kanta Midha ceased to be Director on 20 Nov 2017. Hemant Kumar ceased to be Director on 20 Nov 2017. Vandana Midha ceased to be Director on 20 Nov 2017. Sirrus Pharmaceuticals has 8 board changes on record in total.
Yes, Sirrus Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-06-0030455).
The registered office of Sirrus Pharmaceuticals is at 153 Venus Appartment Sector – 9 Rohini, New Delhi, Delhi, India – 110085.
Sirrus Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages